Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. LEN
7. APO
8. TLT
9. BETR
10. AMZN

Go back to Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001
AVALON PHARMA (NASDAQ: AVRX) Delayed: 0.59 --0 (-0%)
Previous Close $0.59    52 Week High $1.45 
Open $0.59    52 Week Low $0.07 
Day High $0.59    P/E N/A 
Day Low $0.59    EPS $-1.24 
Volume 35,400       

(NASDAQ: NXTC) Delayed: 6.38 +0.35 (5.80%)
Previous Close $6.03    52 Week High $ 
Open $6.05    52 Week Low $ 
Day High $6.38    P/E N/A 
Day Low $6.05    EPS $ 
Volume 7,729